Morgan Stanley’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Morgan Stanley's BCAT Position: Q2 2026 in Review
Morgan Stanley reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 17% in Q2 2026, selling an estimated $11.6M and leaving 3,603,068 shares worth $57.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.
Morgan Stanley first reported a position in BCAT in Q3 2020 and has held it in 24 quarters since. The position peaked at $226M in Q4 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Morgan Stanley held 3,603,068 shares of BlackRock Capital Allocation Term Trust worth $57.4M as of Q2 2026.
- Morgan Stanley sold 756,684 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $11.6M.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2092 holding.
- Morgan Stanley first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and has held it in 24 quarters since.
- Morgan Stanley's BlackRock Capital Allocation Term Trust position peaked at $226M in Q4 2023.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.